Sex Differences in GERD
暂无分享,去创建一个
[1] Chuyen T. Nguyen,et al. Overlap of Gastroesophageal Reflux Disease and Functional Dyspepsia and Yield of Esophagogastroduodenoscopy in Patients Clinically Fulfilling the Rome IV Criteria for Functional Dyspepsia , 2022, Frontiers in Medicine.
[2] N. Shaheen,et al. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline , 2022, The American journal of gastroenterology.
[3] J. Y. Lee,et al. Efficacy of Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-Analysis , 2022, Journal of personalized medicine.
[4] T. Charles,et al. Effect of Hormonal Replacement Therapy on Gastroesophageal Reflux Disease and its Complications in Post-Menopausal Women. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] W. Lei,et al. Heartburn Sensation in Non-Erosive Reflux Disease: Pattern of Superficial Sensory Nerves Expressing TRPV1 and Epithelial Cells Expressing ASIC3 Receptors. , 2021, American journal of physiology. Gastrointestinal and liver physiology.
[6] D. Katzka,et al. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges. , 2021, Gastrointestinal endoscopy clinics of North America.
[7] E. Savarino,et al. ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux disease , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[8] M. A. Khan,et al. On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis , 2018, Gastroenterology research and practice.
[9] H. El‐Serag,et al. Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux , 2017, JAMA.
[10] C. Gyawali,et al. Management of Gastroesophageal Reflux Disease. , 2017, Gastroenterology.
[11] R. Fass,et al. Current Trends in the Management of Gastroesophageal Reflux Disease , 2017, Gut and liver.
[12] Nayoung Kim,et al. Sex and Gender Differences in Gastroesophageal Reflux Disease , 2016, Journal of neurogastroenterology and motility.
[13] F. Mearin,et al. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease , 2016, BMC Gastroenterology.
[14] T. Shimosegawa,et al. Gender difference in gastro-esophageal reflux diseases. , 2016, World journal of gastroenterology.
[15] C. Afaneh,et al. Gastroesophageal reflux disease: A review of surgical decision making. , 2016, World journal of gastrointestinal surgery.
[16] C. Ell,et al. Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial , 2015, Current medical research and opinion.
[17] Raul Badillo,et al. Diagnosis and treatment of gastroesophageal reflux disease. , 2014, World journal of gastrointestinal pharmacology and therapeutics.
[18] S. Menon,et al. Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer? , 2014, United European gastroenterology journal.
[19] N. Yamamichi,et al. Background Factors of Reflux Esophagitis and Non-Erosive Reflux Disease: A Cross-Sectional Study of 10,837 Subjects in Japan , 2013, PloS one.
[20] Christopher C Winchester,et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review , 2013, Gut.
[21] K. Vega,et al. Females without reflux symptoms or gastroesophageal reflux disease have less distal esophageal acid exposure than males without reflux symptoms or gastroesophageal reflux disease. , 2013, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[22] M. Vela,et al. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease , 2013, The American Journal of Gastroenterology.
[23] Bryan K. Smith,et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: A prospective intervention trial , 2012, Obesity.
[24] D. Sifrim,et al. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors , 2012, Gut.
[25] S. Johansson,et al. Gastroesophageal reflux disease in primary care: Using changes in proton pump inhibitor therapy as an indicator of partial response , 2012, Scandinavian journal of gastroenterology.
[26] P. Devitt,et al. Effect of sex on symptoms associated with gastroesophageal reflux. , 2011, Archives of surgery.
[27] M. Hongo,et al. Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs—TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan , 2011, Journal of Gastroenterology.
[28] H. El‐Serag,et al. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies , 2010, Alimentary pharmacology & therapeutics.
[29] R. Fass,et al. Nonerosive Reflux Disease (NERD) - An Update , 2010, Journal of neurogastroenterology and motility.
[30] P. Devitt,et al. Impact of Gender and Age on the Long-Term Outcome of Laparoscopic Fundoplication , 2009, World Journal of Surgery.
[31] A. Leodolter,et al. Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis ‐ results from the maintenance phase of the EXPO study , 2009, Alimentary pharmacology & therapeutics.
[32] T. Shimosegawa,et al. Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats , 2009, Scandinavian journal of gastroenterology.
[33] G. Colditz,et al. Postmenopausal hormone use and symptoms of gastroesophageal reflux. , 2008, Archives of internal medicine.
[34] N. Pedersen,et al. Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. , 2008, Gastroenterology.
[35] C. Pellegrini,et al. Long-Term Outcomes After Laparoscopic Antireflux Surgery , 2008, The American Journal of Gastroenterology.
[36] H. S. Kim,et al. The prevalence of and risk factors for erosive oesophagitis and non‐erosive reflux disease: a nationwide multicentre prospective study in Korea , 2007, Alimentary pharmacology & therapeutics.
[37] J. Saltzman,et al. Endoscopic treatment of gastroesophageal reflux disease: Effect of gender on clinical outcome , 2006, Scandinavian journal of gastroenterology.
[38] H. Kagami,et al. Effects of ovariectomy and estrogen replacement on rat oral mucosa. , 2005, Maturitas.
[39] M. Davila,et al. Features of Gastroesophageal Reflux Disease in Women , 2004, American Journal of Gastroenterology.
[40] K. Hveem,et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. , 2003, JAMA.
[41] P. Malfertheiner,et al. Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD Study , 2003, Alimentary pharmacology & therapeutics.
[42] E. Verdu,et al. Modulatory effects of estrogen in two murine models of experimental colitis. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[43] F. Wunderlich,et al. Estradiol Signaling via Sequestrable Surface Receptors. , 2001, Endocrinology.
[44] I. Wiklund,et al. Gastro‐oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole , 1998 .
[45] P. Ask,et al. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. , 1986, Scandinavian journal of gastroenterology.
[46] E. Kovacs,et al. Sex differences and estrogen modulation of the cellular immune response after injury. , 2008, Cellular immunology.